Search

everythinglearnresearchcommunity

for

Search:↓

A systematic approach is crucial for managing hair loss in women.

Combining low-level light therapy and minoxidil 5% is more effective for female hair loss than using either treatment alone.

Diffuse alopecia areata involves more inflammation and higher allergy-related antibodies than patchy types.

Platelet-Rich Plasma (PRP) is a low-risk treatment for Androgenic Alopecia (AGA) that generally improves hair count or density, but more research is needed for optimization.

Most patients with frontal fibrosing alopecia had facial bumps, with Hispanic/Latino and premenopausal women being more affected, suggesting a more severe condition.

Coenzyme Q10 vesicular formulations can potentially treat androgenic alopecia by promoting hair growth and thickness.

Different hair loss types need accurate diagnosis for proper treatment.

Frontal fibrosing alopecia can mimic traction alopecia but has distinct features like facial papules and eyebrow thinning.

Male gender and family history predict alopecia areata recurrence.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

Platelet-rich plasma treatment significantly increased hair regrowth and decreased discomfort in alopecia patients, making it a potentially better and safer treatment option.

Low iron and vitamin D levels are linked to hair loss in women.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Understanding and treating hair disorders in different ethnic groups requires knowledge of specific hair care practices and hair characteristics.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.

Calcipotriol works almost as well as clobetasol for mild to moderate alopecia areata with fewer side effects.

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.

Intralesional triamcinolone acetonide is more effective than platelet-rich plasma for treating scalp alopecia areata.

Less than a quarter of alopecia areata cases were unusual forms or had paradoxical regrowth.

Adding platelet-rich plasma improves hair density and thickness in androgenetic alopecia.

Trichloroacetic acid is a safe and effective treatment for hair loss in alopecia areata patients.

PRP may help hair growth in alopecia areata without major side effects, but more research is needed.

Proretinal nanoparticles are a safe and effective way to deliver retinal to the skin.

The conclusion is that using the 5W1H method can improve diagnosis and management of childhood hair-pulling disorder.

Intralesional triamcinolone is the most effective treatment for alopecia areata, followed by excimer light therapy, and then topical minoxidil. The scalp responds better to treatment than the beard area.

A device was made in 2008 to measure hair loss severity. Other findings include: frizzy mutation in mice isn't related to Fgfr2, C/EBPx marks preadipocytes, Cyclosporin A speeds up hair growth in mice, blocking plasmin and metalloproteinases hinders healing, hyperbaric oxygen helps ischemic wound healing, amniotic membranes heal wounds better than polyurethane foam, rhVEGF165 from a fibrin matrix improves tissue flap viability and induces VEGF-R2 expression, and bFGF enhances wound healing and reduces scarring in rabbits.

Oral tofacitinib may be an effective future treatment for children with severe alopecia areata, but more research is needed.

About 61% of women who had COVID-19 experienced hair loss afterward.

The combination of vitamin D analogues with potent steroids is a favorable treatment for alopecia areata with fewer side effects.

Long-hair follicular unit excision improves hairline restoration results and patient satisfaction.